Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pronai Therap Cmn (DNAI)

Pronai Therap Cmn (DNAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,500
  • Shares Outstanding, K 30,370
  • Annual Sales, $ 0 K
  • Annual Income, $ -53,260 K
  • 60-Month Beta 1.79
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.43
Trade DNAI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.28
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 03/02/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate -0.28
  • Number of Estimates 3
  • High Estimate -0.27
  • Low Estimate -0.31
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +26.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.39 +12.23%
on 12/14/16
1.68 -7.14%
on 01/04/17
-0.05 (-3.11%)
since 12/09/16
3-Month
1.32 +18.18%
on 12/01/16
1.93 -19.17%
on 10/12/16
-0.24 (-13.33%)
since 10/07/16
52-Week
1.32 +18.18%
on 12/01/16
12.94 -87.94%
on 01/11/16
-10.53 (-87.10%)
since 01/08/16

Business Summary

ProNAi Therapeutics, Inc. is an oncology company. The Company develops therapies on its deoxyribonucleic acid interference technology platform to treat cancer and hematological diseases. Its product candidate consists of PNT2258 which treat cancers that overexpress BCL2, an oncogene known to be dysregulated...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.70
1st Resistance Point 1.63
Last Price 1.56
1st Support Level 1.51
2nd Support Level 1.46
3rd Support Level N/A

See More

52-Week High 12.94
Fibonacci 61.8% 8.50
Fibonacci 50% 7.13
Fibonacci 38.2% 5.76
Last Price 1.56
52-Week Low 1.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar